Back to Invesco Ltd. Invesco Ltd.

HALOHALO
Showing 8 of 23 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in HALOZYME THERAPEUTICS INC

Invesco Ltd. holds 3.2M shares of HALO (HALOZYME THERAPEUTICS INC), worth $248.7M as of 2026-Q2. The position was decreased (-20.8% shares). HALO represents 0.0% of Invesco Ltd.'s portfolio.

Current Value

$248.7M

Current Shares

3.2M

Total Value Change

+$139.3M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3.2M
-20.8%
$248.7M0.0%$78.27
0
2026-Q1
Increased
4M
+10.0%
$259.3M0.0%$69.40
34
2025-Q4
Increased
3.6M
+12.4%
$245.5M0.0%$67.70
35
2025-Q3
Decreased
3.2M
-6.3%
$238M0.0%$73.29
0
2025-Q2
Decreased
3.5M
-11.0%
$180.3M0.0%$52.21
0
2025-Q1
Increased
3.9M
+64.0%
$248.5M0.0%$63.84
45
2024-Q4
Increased
2.4M
+24.2%
$113.5M0.0%$47.99
37
2024-Q3
Decreased
1.9M
-14.0%
$109.4M0.0%$56.97
0

Other major holders of HALO: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used